ABBOTT INDIA LIMITED

🇮🇳India

Country: 🇮🇳India

Ownership: Private

Established: 1888-01-01

Employees: 73K

Market Cap: $7.5B

Website: http://www.abbott.com

Clinical Trials

Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Phase 2

Completed

Conditions: Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis

Interventions: Drug: Creon IR
Drug: Creon® (DR/GR)

First Posted Date: 2015-04-14

Last Posted Date: 2016-04-04

Lead Sponsor: Abbott

Target Recruit Count: 70

Registration Number: NCT02415959

Locations: 🇨🇿
Dětská nemocnice FN Brno, Centrum pro cystickou fibrozu, Brno, Czech Republic
🇨🇿
Klinika nemocí plicních a TBC, Brno, Czech Republic
🇭🇺
Magyar Imre Kórház, Ajka, Hungary

and more 14 locations

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

Phase 3

Completed

Conditions: Influenza

Interventions: Biological: Trivalent influenza subunit vaccine Influvac

First Posted Date: 2015-03-06

Last Posted Date: 2016-12-22

Lead Sponsor: Abbott

Target Recruit Count: 120

Registration Number: NCT02381418

Locations: 🇦🇺
Research Facility ID ORG-001075, Maroubra, Australia

A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]

Completed

Conditions: Hepatic Encephalopathy

First Posted Date: 2015-03-04

Last Posted Date: 2020-02-10

Lead Sponsor: Abbott

Target Recruit Count: 50

Registration Number: NCT02377947

Locations: 🇮🇳
Medanta Hospital, Gurgaon, India
🇮🇳
Sir Ganga Ram Hospital, New Delhi, India
🇮🇳
Research facility ORG-000333, Gurgaon, India

Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians

Completed

Conditions: Urinary Tract Infections (UTIs)

First Posted Date: 2014-12-02

Last Posted Date: 2015-03-06

Lead Sponsor: Abbott

Target Recruit Count: 350

Registration Number: NCT02305342

Locations: 🇵🇰
Research facility ID ORG-001126, Karachi, Pakistan

An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes

Completed

Conditions: Hypertension

First Posted Date: 2014-11-24

Last Posted Date: 2018-03-27

Lead Sponsor: Abbott

Target Recruit Count: 270

Registration Number: NCT02298556

Locations: 🇹🇷
Research facility ID ORG-001030, Ankara, Turkey
🇹🇷
Research facility ID ORG-001111, Antalya, Turkey
🇹🇷
Research facility ID ORG-001108, Adana, Turkey

and more 20 locations

Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointestinal Spasm

Completed

Conditions: Post-cholecystectomy Gastrointestinal Spasms

Interventions: Drug: Mebeverine

First Posted Date: 2014-10-09

Last Posted Date: 2019-06-06

Lead Sponsor: Abbott

Target Recruit Count: 220

Registration Number: NCT02260154

Locations: 🇷🇺
Research Facility ID ORG-001038, Izhevsk, Russian Federation
🇷🇺
State Budget Institution " Irkutsk State Medical Academy of postgraduate education", Irkutsk, Russian Federation
🇷🇺
Research Facility ID ORG-001035, Chita, Russian Federation

and more 18 locations

Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis

Phase 3

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: placebo
Drug: Phleum pratense grass pollen allergen extract

First Posted Date: 2014-09-19

Last Posted Date: 2016-01-11

Lead Sponsor: Abbott

Target Recruit Count: 107

Registration Number: NCT02245360

Locations: 🇷🇺
Research facility ID ORG-001014, Moscow, Russian Federation
🇷🇺
Research facility ID ORG-001006, Moscow, Russian Federation
🇷🇺
Research facility ID ORG-001016, Moscow, Russian Federation

and more 12 locations

To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.

Completed

Conditions: Vertigo

First Posted Date: 2014-08-11

Last Posted Date: 2015-05-28

Lead Sponsor: Abbott

Target Recruit Count: 400

Registration Number: NCT02213120

Locations: 🇵🇰
Research facility ID ORG-001139, Hyderabad, Pakistan
🇵🇰
Research facility ID ORG-001070, Karachi, Pakistan
🇵🇰
Research facility ID ORG-001051, Karachi, Pakistan

and more 8 locations

Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption

Phase 3

Completed

Conditions: Intrahepatic Cholestasis Associated With Alcoholic Liver Disease

Interventions: Drug: Ademetionine IV+tablet
Drug: Ademetionine tablet

First Posted Date: 2014-07-25

Last Posted Date: 2015-06-16

Lead Sponsor: Abbott

Target Recruit Count: 75

Registration Number: NCT02200029

Locations: 🇷🇺
Research facility ORG-000961, Moscow, Russian Federation
🇷🇺
Research facility ORG-000967, St. Petersburg, Russian Federation
🇷🇺
Research facility ORG-000966, St. Petersburg, Russian Federation

and more 9 locations

A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Phase 3

Completed

Conditions: Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Interventions: Drug: Creon N
Drug: Creon®

First Posted Date: 2014-05-13

Last Posted Date: 2016-01-22

Lead Sponsor: Abbott

Target Recruit Count: 41

Registration Number: NCT02137382

Locations: 🇭🇺
Research facility ID ORG-000825, Törökbálint, Hungary
🇭🇺
Research facility ID ORG-000816, Debrecen, Hungary
🇭🇺
Research facility ID ORG-000826, Budapest, Hungary

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy